UAB30

· University of Alabama at Birmingham

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UAB30, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer [Phase 1, Phase 2]

See pricing